Article
Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease
9 Dec 2019
Abstract excerpt
This phase 2 clinical trial in patients with high-risk sickle cell disease assesses the feasibility, safety, and 1-year event-free survival after myeloimmunoablative conditioning and familial haploidentical stem cell transplant.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
